% Expired Patents = 20.0

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 9

Loading Chart...

13 inventors (with patents filed for the assignee):

Frank Tufaro (4 out of 4 patents)

Juan Fueyo-Margareto (3 out of 5 patents)

Candelaria Gomez-Manzano (3 out of 9 patents)

4. Charles A Conrad (3 out of 22 patents)

5. W K Alfred Yung (2 out of 6 patents)

6. Frederick Lang, Jr (2 out of 4 patents)

7. Amy Heimberger (2 out of 4 patents)

8. Hong Jiang (1 out of 2 patents)

9. Joanna J Peterkin (1 out of 1 patent)

10. Wk Alfred Yung (1 out of 2 patents)

11. Manel Maria Cascallo Piqueras (1 out of 4 patents)

12. Ramon Alemany Bonastre (1 out of 7 patents)

13. Juan Jose Rojas Exposito (1 out of 1 patent)

14. Juan Fueyo (4 patents)

15. Candeleria Manzano-Gomez (0 patent)

5 patents: Sort by Forward Citations

1. 11110137 - Combination therapy for treatment of brain cancers (2021-09-07),

2. 11090344 - Adenovirus and immunomodulator combination therapy (2021-08-17),

3. 11065285 - Biomarkers and combination therapies using oncolytic virus and immunomodulation (2021-07-20),

4. 10238698 - Biomarkers and combination therapies using oncolytic virus and immunomodulation (2019-03-26),

5. 10016470 - Oncolytic adenoviruses for cancer treatment (2018-07-10),

Dnatrix, Inc. is a biotechnology company focused on developing innovative gene therapy solutions. We specialize in designing and delivering DNA-based therapeutics to treat a variety of diseases. Our cutting-edge technology allows for precise targeting and efficient delivery of genetic material, paving the way for personalized medicine and improved patient outcomes.

Profile summary based on public USPTO records.